Johnson & Johnson
Change company Symbol lookup
Select an option...
JNJ Johnson & Johnson
PTI Proteostasis Therapeutics Inc
CALB California BanCorp
$NOPM2 Refinitiv Norway Metal & Mining Inde
EBAY eBay Inc
PTON Peloton Interactive Inc
GO Grocery Outlet Holding Corp
NUE Nucor Corp
SJM J M Smucker Co
KR Kroger Co

Health Care : Pharmaceuticals | Large Cap Blend
Company profile

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer segment includes a range of products used in the baby care, oral care, skin care, over-the-counter pharmaceutical, women's health and wound care markets. The Pharmaceutical segment is focused on five therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment includes a range of products used in the orthopedic, surgery, cardiovascular, diabetes care and vision care fields. Its research facilities are located in the United States, Belgium, Brazil, Canada, China, France, Germany, India, Israel, Japan, the Netherlands, Singapore, Switzerland and the United Kingdom.


Last Trade
0.04 (0.03%)
B/A Size

Market Hours

Closing Price
Day's Change
0.00 (0.00%)
B/A Size
Day's High
Day's Low
(Heavy Day)

10-day average volume:

UPDATE: Chipotle sales bounce back from pandemic decline, but the stock is falling

7:48 am ET October 22, 2020 (MarketWatch)

By Jeremy C. Owens

After huge stock run-up amid gains in online ordering and ticket size, Chipotle shares drop about 5% in after-hours action despite return to revenue growth, better-than-expected earnings

Chipotle Mexican Grill Inc. returned to sales growth despite the COVID-19 pandemic over the summer, the company reported on Wednesday, but shares still declined after a sustained run higher.

Chipotle (CMG) reported third-quarter net income of $80.2 million, or $2.82 a share, down from $3.47 a share last year due to costs related to restructuring, restaurant closures and legal proceedings, the company said. After adjusting for those costs, the company reported earnings of $3.76 a share, down from $3.82 a share a year ago.

Revenue jumped back to growth, however. Sales totaled $1.6 billion, up more than 14% from $1.4 billion a year ago, thanks to a same-store-sales gain of 8.3%. Analysts on average expected same-store sales to gain 7.3%, according to FactSet, and projected adjusted earnings of $3.47 a share on sales of $1.59 billion.

Chipotle has leveraged online ordering and delivery ( to recover quickly from the effects of the COVID-19 pandemic. The Mexican-food chain's same-store sales declined in the second quarter but has bounced back in part thanks to larger orders and the return of carne asada (

Online sales continue to be a huge driver of purchases in the third quarter, with online sales more than tripling and accounting for nearly half of the orders Chipotle received.

"Digital sales grew 202.5% year over year to $776.4 million and represented 48.8% of sales," the company disclosed in Wednesday's release. "About half of the digital sales were via delivery, benefiting from our expanded partnerships, with the remainder coming from order-ahead transactions."

Chipotle did not provide a forecast for the current quarter due to "ongoing uncertainty surrounding the future impact of COVID-19 on the broader US economy and any specific impact to our company," according to the release.

Shares dropped about 5% in after-hours trading immediately following the release of the results, after closing with a 1% gain at $1,361.58 in the regular trading session. The stock was down the same amount premarket Thursday, and is up more than 60% so far this year, as the S&P 500 index SPX (#phrase-company?ref=COMPANY%7CSPX;onlineSignificance=passing-mention) has increased 6.6%.

-Jeremy C. Owens; 415-439-6400;

(END) Dow Jones Newswires

October 22, 2020 07:48 ET (11:48 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.